Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16610162rdf:typepubmed:Citationlld:pubmed
pubmed-article:16610162lifeskim:mentionsumls-concept:C0029456lld:lifeskim
pubmed-article:16610162lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:16610162pubmed:issue4lld:pubmed
pubmed-article:16610162pubmed:dateCreated2006-4-13lld:pubmed
pubmed-article:16610162pubmed:abstractTextOsteoporosis can occur as a result of liver cirrhosis. The pathogenesis of reduced bone mineral density in liver cirrhosis is multifactorial. It can be caused by alterations in calcium and vitamin D homeostasis, as well as nutritional and dietary factors. Dual-energy X-ray absorptiometry (DXA) has become the gold standard in assessing bone mineral density in patients with liver cirrhosis. In such cases, patients can be treated with calcium and vitamin D supplements, bisphosphonates and hormonal replacement therapy (HRT).lld:pubmed
pubmed-article:16610162pubmed:languageenglld:pubmed
pubmed-article:16610162pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16610162pubmed:citationSubsetIMlld:pubmed
pubmed-article:16610162pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16610162pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16610162pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16610162pubmed:statusMEDLINElld:pubmed
pubmed-article:16610162pubmed:issn0048-7848lld:pubmed
pubmed-article:16610162pubmed:authorpubmed-author:ZbrancaEElld:pubmed
pubmed-article:16610162pubmed:authorpubmed-author:DrugV LVLlld:pubmed
pubmed-article:16610162pubmed:authorpubmed-author:CijevschiCris...lld:pubmed
pubmed-article:16610162pubmed:authorpubmed-author:MihaiC?t?lina...lld:pubmed
pubmed-article:16610162pubmed:authorpubmed-author:Gog?lniceanuP...lld:pubmed
pubmed-article:16610162pubmed:issnTypePrintlld:pubmed
pubmed-article:16610162pubmed:volume109lld:pubmed
pubmed-article:16610162pubmed:ownerNLMlld:pubmed
pubmed-article:16610162pubmed:authorsCompleteYlld:pubmed
pubmed-article:16610162pubmed:pagination700-4lld:pubmed
pubmed-article:16610162pubmed:dateRevised2011-1-13lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:meshHeadingpubmed-meshheading:16610162...lld:pubmed
pubmed-article:16610162pubmed:articleTitleOsteoporosis in liver cirrhosis--overview.lld:pubmed
pubmed-article:16610162pubmed:affiliationGastroenterology and Hepatology Institute Ia?i, "Gr.T. Popa" University of Medicine and Pharmacy, Ia?i.lld:pubmed
pubmed-article:16610162pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16610162pubmed:publicationTypeReviewlld:pubmed